Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.34 |
| ▸ | VEGFA | P15692 | 1/20 | 0.34 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL92056 | 0.88 | ALDH1A1 (0.50) | ALDH1A1CYP3A4TDP1 | |
| SCHEMBL12692354 | 0.86 | ACHE (0.42) | ALDH1A1CYP3A4TDP1 | |
| SCHEMBL13410607 | 0.86 | ACHE (0.42) | ALDH1A1CYP3A4TDP1 | |
| SCHEMBL13019607 | 0.86 | ALDH1A1 (0.48) | ALDH1A1 | |
| SCHEMBL13019481 | 0.84 | MAPT (0.55) | TP53CYP3A4 | |
| SCHEMBL13019483 | 0.80 | KIF11 (0.54) | ALDH1A1 | |
| SCHEMBL13019484 | 0.80 | MMP3 (0.52) | ALDH1A1 | |
| SCHEMBL2757247 | 0.75 | HPGDS (0.42) | EGLN1VEGFAEGLN3 | |
| SCHEMBL12360610 | 0.75 | ENPP3 (0.45) | ALDH1A1TP53 | |
| SCHEMBL13037668 | 0.75 | MMP3 (0.47) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-11374082-B2 | Electronic device and method of manufacturing electronic device, and electronic apparatus | Sony Group Corporation (JP) | 2022-06-28 | — | — | US | disclosed |
| US-10791593-B2 | Organic EL display unit, method of manufacturing the same, and electronic apparatus | SONY CORPORATION (JP) | 2020-09-29 | — | — | US | disclosed |
| EP-3125277-B1 | SEMICONDUCTOR ELEMENT COMPRISING INSULATING LAYER-FORMING COMPOSITION | FUJIFILM CORP (JP) | 2020-06-03 | — | — | EP | disclosed |
| EP-3240056-B1 | ORGANIC SEMICONDUCTOR LIQUID COMPOSITION AND METHOD OF PRODUCING ORGANIC SEMICONDUCTOR ELEMENT USING SAID COMPOSITION | FUJIFILM CORP (JP) | 2020-04-22 | — | — | EP | disclosed |
| EP-3116033-B1 | THIN-FILM TRANSISTOR | FUJIFILM CORP (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-10482798-B2 | Display unit and electronic apparatus | MAGNOLIA BLUE CORPORATION (JP) | 2019-11-19 | — | — | US | disclosed |
| US-10341475-B2 | Display unit, method of manufacturing the same, and electronic apparatus | SONY CORPORATION (JP) | 2019-07-02 | — | — | US | disclosed |
| US-20190096290-A1 | DISPLAY UNIT AND ELECTRONIC APPARATUS | MAGNOLIA BLUE CORPORATION (JP) | 2019-03-28 | — | — | US | disclosed |
| US-20190008015-A1 | ORGANIC EL DISPLAY UNIT, METHOD OF MANUFACTURING THE SAME, AND ELECTRONIC APPARATUS | SONY CORP (JP) | 2019-01-03 | — | — | US | disclosed |
| US-20080213916-A1 | Allosterically Catalyzed Signal Amplification in Chemical and Biological Sensing | NORTHWESTERN UNIVERSITY (US) | 2008-09-04 | — | — | US | disclosed |
| US-20080012010-A1 | ORGANIC ELECTRONIC DEVICE, METHOD FOR PRODUCTION THEREOF, AND ORGANIC SEMICONDUCTOR MOLECULE | SONY CORPORATION (JP) | 2008-01-17 | — | — | US | disclosed |
| US-20080012010-A1 | ORGANIC ELECTRONIC DEVICE, METHOD FOR PRODUCTION THEREOF, AND ORGANIC SEMICONDUCTOR MOLECULE | SONY CORPORATION (JP) | 2008-01-17 | — | — | US | disclosed |
| US-7186634-B2 | Method for forming metal single-layer film, method for forming wiring, and method for producing field effect transistors | SONY CORPORATION (JP) | 2007-03-06 | — | — | US | disclosed |
| US-20060027860-A1 | Field-effect transistor | SONY CORPORATION (JP) | 2006-02-09 | — | — | US | disclosed |
| US-20060024860-A1 | Semiconductor apparatus and process for fabricating the same | WADA MASARU | 2006-02-02 | — | — | US | disclosed |
| EP-1519418-A1 | SEMICONDUCTOR DEVICE AND METHOD FOR MANUFACTURING SAME | Sony Corporation (JP) | 2005-03-30 | — | — | EP | disclosed |
| US-20050056828-A1 | Semiconductor device and method for manufacturing same | SONY CORPORATION (JP) | 2005-03-17 | — | — | US | disclosed |
| US-20050059193-A1 | Method for forming metal single-layer film, method for forming wiring, and method for producing field effect transistors | SONY CORPORATION (JP) | 2005-03-17 | — | — | US | disclosed |
| EP-1515378-A2 | Method of forming electrodes for field effect transistors | SONY CORPORATION (JP) | 2005-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080213916-A1 | Allosterically Catalyzed Signal Amplification in Chemical and Biological Sensing | CASR, MAVS, STAT3 | EGLN1 4103/4885VEGFA 4869/4885EGLN3 4719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.